Pre-Filled Syringes Americas
31 March 2014 - 01 April 2014
With unit sales of 3.59 billion predicted in 2015, pre-filled syringes form one of the fastest growing markets in healthcare. The companies that will thrive in this marketplace will be those able to deliver products to market with the shortest lead times and longest shelf life.
Pre-Filled Syringes Americas is the western hemisphere's industry forum. The world’s biopharmaceutical companies will be gathering to discuss how the latest developments in drug stabilisation and material interactions are reshaping the drug delivery industry.
Renaissance Woodbridge Hotel, Iselin, New Jersey, USA
http://www.smi-online.co.uk/pharmaceuticals/northamerica/conference/Pre-Filled-Syringes-Americas
Discovery Summit 2014
31 March 2014 - 01 April 2014
The 14th Annual Global Discovery Summit is the premium forum bringing elite buyers and sellers together. As an invitation-only event taking place behind closed doors, the summit offers global R&D professionals and drug discovery service providers an intimate environment for a focused discussion of key new drivers shaping discovery research and development.
Grande Real Villa Itália Hotel & Spa, Cascais, Lisbon
http://www.discovery-summit.com/
Asthma & COPD
02 April 2014 - 03 April 2014
There is a growing demand for the next generation of inhaled combination products and novel therapeutics. This conference will enable delegates to gain valuable insight into the latest ground-breaking advances in the respiratory drug market. It will focus on the challenges and strategies to enhance patient outcomes, providing extensive knowledge from the key leading industry and academic experts.
The agenda will focuss on the treatment for exacerbations, clinical trial design and strategies for method enhancement, biomarkers and the utilisation of devices for Asthma and COPD. Key focus will be put on the anti-inflammatory developments in addition to the efficacy and toxicological issues relating to combination products.
Marriott Hotel, Regents Park, London, UK
http://www.smi-online.co.uk/pharmaceuticals/uk/conference/asthma-copd
Biosimilars and Biobetters USA
07 April 2014 - 08 April 2014
As the expiration of patent protection for several top-selling biologicals over the next decade draws closer, this is predicted to open up an estimated US$24 billion in EU sales and US$30 billion in US sales of biosimilars. With the potentially rapid growth of this market, biosimilar manufacturers are set to make a ‘beeline’ towards this lucrative opportunity.
Despite having to overcome a number of commercial, regulatory, financial and business challenges, the anticipated establishment of robust FDA regulatory guidelines, coupled with the economic need for cheaper biological drugs is expected to add momentum to the growth of the USA biosimilars industry.
Renaissance Woodbridge Hotel, Iselin, New Jersey, USA
http://www.smi-online.co.uk/pharmaceuticals/northamerica/conference/BioSimilars-USA
Regulatory challenges and opportunities in antibiotic drug development and registration
08 April 2014
Much is happening globally in the world of antibiotic research, development, licencing and use. The paucity of new antibiotics for the effective treatment of multidrug gram negative infections over the last 10 years coupled with the inexorable rise of these organisms has led to claims for a disaster soon to happen. This has been likened to the global effects of climate change but this bacterial threat is already causing increased morbidity and mortality. Many proposals have been made by a large number of stakeholders including researchers, developers, regulatory bodies and payers recently.
This masterclass will deal with issues related to the opposing forces of investment, research and development when constructing a commercial forecast for a novel agent.
tbc London, UK
http://www.smi-online.co.uk/pharmaceuticals/uk/masterclass/regulatory-challenges-and-opportunities-in-antibiotic-drug-development-and-registration?utm_source=MC353&utm_medium=EM%20-%20MM&utm_campaign=GroupMail
7th Diabetes Drug Discovery and Development Conference
23 April 2014 - 25 April 2014
The International Diabetes Federation estimates that more than 285 million people world-wide have diabetes and 438 million people will have this disease within 20 years. Type 2 Diabetes Mellitus (T2DM) accounts for more than 90% of all diabetes and is characterized by insulin resistance combined with relatively reduced insulin secretion. The seven major markets for diabetes are expected to grow to 35 billion in 10 years driven by patient population expansion and novel therapies.
Come and join other diabetes experts at GTC’s 7th Diabetes Drug Discovery and Development Conference and hear key thought-leader's opinions to these questions and many more. This important meeting will be held on April 23-25, 2014 in Cambridge, MA. The conference will bring together the leading experts on diabetes from both industry and academia to discuss novel targets for diabetes, lessons to learn from current and clinical drug development.
Hyatt Regency Cambridge, MA, USA
http://www.gtcbio.com/conference/diabetes-drug-discovery-and-development-overview?utm_source=post+conference&utm_medium=website&utm_campaign=diabetesdd
Fragment Based Drug Discovery
24 April 2014 - 25 April 2014
There are at least 25 disclosed drug candidates forging ahead in clinical development whose origins can be traced to fragment-based screening campaigns. Fragment-based approaches for finding potential new medical therapies are now a part of many drug discovery programs. However, medicinal chemists, especially in larger companies with high throughput screening departments, have other sources for ‘hits’ to optimize into lead drug candidates. What is the exact role and usefulness of fragment-based screening nowadays? How is it changing? How can it be improved? How can it be better integrated or used synergistically with other approaches?
Join fellow discovery chemists at Cambridge Healthtech Institute’s ‘Fragment-Based Drug Discovery’ meeting to hear case studies of ‘successes’ and more. Follow a fragment from discovery through its optimization into a clinical candidate. Benefit from a continuous perspective on what is usually a disconnected story. Discuss with colleagues new concepts in library design, such as shape and target-specialized libraries. The meeting will also address the biggest challenge in fragment-based drug design, optimization of fragment hits to get to better drugs.
Hilton San Diego Resort & Spa, San Diego, CA, USA
http://www.drugdiscoverychemistry.com/Fragment-Based-Drug-Discovery
7th Annual World Protein and Peptide Conference. PepCon-2014
25 April 2014 - 28 April 2014
The 7th World Protein and Peptide Conference 2014 will be held on April 25-28, 2014, in Dalian, China. There also will be 7 other meetings holding with PepCon-2014. The organizing committee of PepCon-2014 devotes itself to supply the most cutting-edge technology information to you. During the congress, we will set up a serious of activities such as Scientific Programme, Exhibition, Posters and so on.
International Conference Center, Dalian, China
http://www.bitlifesciences.com/PepCon2014/default.asp
BIT's 6th Annual World Congress of Vaccine (WCV-2014)
25 April 2014 - 28 April 2014
Following on the successful organizing of WCV-2013, we are pleased to announce the next WCV conference will be held during April 25-28, 2014 in Dalian, China. With the theme of "Voice of Global Health", we will once again offer professionals in the field of vaccine a multidisciplinary informative platform.
International Conference Center, Dalian, China
http://www.bitlifesciences.com/wcv2014/